All In Biotech

Drug Trial Radar · NCT06780306

A Study in the Treatment of Mild to Moderate Dry Eye Disease Comparing Saline to TTAX03.

A Phase 2 Randomized, Controlled, Multicenter, Dose Optimization Study of TTAX03 in the Treatment of Mild to Moderate Dry Eye Disease (DED)

Last checked: Nov 19, 2026Latest source record: Feb 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

74

Actual

Start

Dec 12, 2024

Primary completion

Jan 30, 2026

Study completion Jan 30, 2026

Sponsor

Lead sponsor
BioTissue Holdings, IncIndustry
Sponsor type
Industry
First posted
Jan 17, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this randomized, controlled, multicenter study is to evaluate the safety and efficacy of TTAX03 in participants with mild to moderate DED. The primary question it aims to answer is if TTAX03 is safe. The secondary is the effectiveness. Researchers will compare 10mg of TTAX03 reconstituted in 150, 300, or 600 uL saline to the saline control group to look at effectiveness. Participants will be randomized to a treatment group one time and be evaluated at 5 different study visits.

Conditions

  • Dry Eye
  • Dry Eye Disease (DED)
  • Dry Eye Disease With Severe Keratitis

Interventions

  • TTAX03Biological

    Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord

  • Saline (NaCl 0,9 %) (placebo)Biological

    300 mL Sterile, preservative free 0.9% NaCl

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Determine 12 week ocular and general safety after application of TTAX03.Time frame: 12 weeks

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • University California Berkeley

    Berkeley, California

  • Advanced Research, LLC.

    Deerfield Beach, Florida

  • Southwest Eye Care

    Chaska, Minnesota

  • University of Mississippi Medical Center

    Jackson, Mississippi

  • Eye Associates of North Jersey

    Dover, New Jersey

  • Northern New Jersey Eye Institute

    South Orange, New Jersey

  • Wilmington Eye at Brunswick Forest

    Leland, North Carolina

  • CORE, Inc. / Vita Eye Clinic

    Shelby, North Carolina

  • Westlake Eye Specialists

    Austin, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.